AJP - Heart AJP: Heart and Circulatory Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 287: H2369-H2375, 2004. First published July 29, 2004; doi:10.1152/ajpheart.00422.2004
0363-6135/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/6/H2369    most recent
00422.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (21)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xi, L.
Right arrow Articles by Kukreja, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xi, L.
Right arrow Articles by Kukreja, R. C.

Cobalt chloride induces delayed cardiac preconditioning in mice through selective activation of HIF-1{alpha} and AP-1 and iNOS signaling

Lei Xi, Mohiuddin Taher, Chang Yin, Fadi Salloum, and Rakesh C. Kukreja

Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia 23298-0281

Submitted 6 May 2004 ; accepted in final form 23 July 2004

Acute systemic hypoxia induces delayed cardioprotection against ischemia (I)-reperfusion (R) injury via inducible nitric oxide synthase (iNOS)-dependent mechanism. Because CoCl2 is known to elicit hypoxia-like responses, we hypothesized that this chemical would mimic the delayed preconditioning effect in the heart. Adult male mice were pretreated with CoCl2 or saline. The hearts were isolated 24 h later and subjected to 20 min of global I and 30 min of R in Langendorff mode. Myocardial infarct size (% of risk area; mean ± SE, n = 6–8/group) was reduced in mice pretreated with 30 mg/kg CoCl2 (16.1 ± 3.1% vs. 27.6 ± 3.3% with saline control; P < 0.05) without compromising postischemic cardiac function. Higher doses of CoCl2 failed to induce similar protection. Electrophoretic mobility gel shift assay demonstrated significant enhancement in DNA binding activity of hypoxia-inducible factor 1{alpha} (HIF-1{alpha}) and activator protein 1 (AP-1) in nuclear extracts from CoCl2-treated hearts. Activation of HIF-1{alpha} and AP-1 was evident at 30 min and sustained for the next 4 h after CoCl2 injection. In contrast, CoCl2-induced protection was independent of NF-{kappa}B activation because no DNA binding or p65 translocation was observed in nuclear extracts. Also, CoCl2-induced cardioprotection was preserved in p50 subunit NF-{kappa}B-knockout (KO) mice (11.1 ± 3.0% vs. 25.1 ± 5.0% in saline-treated p50-KO mice; P < 0.05). The infarct-limiting effect of CoCl2 was absent in iNOS-KO mice (20.9 ± 3.0%). We conclude that in vivo administration of CoCl2 preconditions the heart against I/R injury. The delayed protective effect of CoCl2 is achieved through a distinctive signaling mechanism involving HIF-1{alpha}, AP-1, and iNOS but independent of NF-{kappa}B activation.

ischemia-reperfusion injury; myocardial infarction; hypoxia; nitric oxide synthase; transcription factors



Address for reprint requests and other correspondence: R. C. Kukreja, Division of Cardiology, Box 980281, Virginia Commonwealth Univ., Richmond, VA 23298-0281 (E-mail: rakesh{at}hsc.vcu.edu)




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. Belaidi, P. C. Beguin, P. Levy, C. Ribuot, and D. Godin-Ribuot
Prevention of HIF-1 activation and iNOS gene targeting by low-dose cadmium results in loss of myocardial hypoxic preconditioning in the rat
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H901 - H908.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
P. Hill, D. Shukla, M. G.B. Tran, J. Aragones, H. T. Cook, P. Carmeliet, and P. H. Maxwell
Inhibition of Hypoxia Inducible Factor Hydroxylases Protects Against Renal Ischemia-Reperfusion Injury
J. Am. Soc. Nephrol., January 1, 2008; 19(1): 39 - 46.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
F. Prefumo, D. C Gaze, A. T Papageorghiou, P. O Collinson, and B. Thilaganathan
First trimester maternal serum ischaemia-modified albumin: a marker of hypoxia-ischaemia-driven early trophoblast development
Hum. Reprod., July 1, 2007; 22(7): 2029 - 2032.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. Gross, G. Buchwalter, H. Dubois-Pot, E. Cler, H. Zheng, and B. Wasylyk
The Ternary Complex Factor Net Is Downregulated by Hypoxia and Regulates Hypoxia-Responsive Genes
Mol. Cell. Biol., June 1, 2007; 27(11): 4133 - 4141.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. M. Bell, J. E. Clark, D. J. Hearse, and M. J. Shattock
Reperfusion kinase phosphorylation is essential but not sufficient in the mediation of pharmacological preconditioning: Characterisation in the bi-phasic profile of early and late protection
Cardiovasc Res, January 1, 2007; 73(1): 153 - 163.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. K. Kudej, Y.-T. Shen, A. P. Peppas, C.-H. Huang, W. Chen, L. Yan, D. E. Vatner, and S. F. Vatner
Obligatory Role of Cardiac Nerves and {alpha}1-Adrenergic Receptors for the Second Window of Ischemic Preconditioning in Conscious Pigs
Circ. Res., November 24, 2006; 99(11): 1270 - 1276.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. Natarajan, F. N. Salloum, B. J. Fisher, R. C. Kukreja, and A. A. Fowler III
Hypoxia Inducible Factor-1 Activation by Prolyl 4-Hydroxylase-2 Gene Silencing Attenuates Myocardial Ischemia Reperfusion Injury
Circ. Res., January 6, 2006; 98(1): 133 - 140.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Sports. Med.Home page
G Lippi, M Franchini, and G C Guidi
Cobalt chloride administration in athletes: a new perspective in blood doping?
Br. J. Sports Med., November 1, 2005; 39(11): 872 - 873.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.